Blueprint Medicines SG&A Expenses 2014-2024 | BPMC
- Blueprint Medicines annual sg&a expenses for 2023 were $0.295B, a 24.34% increase from 2022.
- Blueprint Medicines annual sg&a expenses for 2022 were $0.237B, a 21.55% increase from 2021.
- Blueprint Medicines annual sg&a expenses for 2021 were $0.195B, a 23.8% increase from 2020.